logo
New WHO agreement on pandemic response: What's it is and what it will do

New WHO agreement on pandemic response: What's it is and what it will do

With lessons from Covid-19, WHO members back treaty to improve equity, vaccine access, and emergency coordination during future outbreaks
Barkha Mathur New Delhi
World Health Organization (WHO) member states have adopted a landmark agreement aimed at addressing the gaps exposed during the Covid-19 pandemic. The WHO Pandemic Agreement is designed to ensure faster, fairer and more coordinated global responses during future health emergencies.
What is the WHO Pandemic Agreement?
The WHO Pandemic Agreement is the first legally binding international accord to comprehensively address pandemic prevention, preparedness, and response. Adopted under Article 19 of the WHO Constitution, it promotes data sharing, equitable access to resources and greater cooperation between countries during health crises.
The agreement text states that member countries recognise 'that the international spread of disease is a global threat… that calls for the widest possible international and regional collaboration… while reaffirming the principle of the sovereignty of States in addressing public health matters.'
What are the goals of the WHO pandemic treaty?
The agreement outlines five primary objectives:
Ensure equitable access to pandemic-related vaccines, treatments, and diagnostics
Strengthen collaboration through data and pathogen sharing
Support resilient health systems, especially in low-resource settings
Promote knowledge and technology transfer for local production
Establish sustainable funding mechanisms for rapid response
How will countries benefit from the pandemic agreement?
Countries that sign and ratify the agreement will be entitled to:
Rapid access to 20 per cent of global pandemic-related health product output — 10 per cent as donations, 10 per cent at affordable prices
A Global Supply Chain and Logistics Network (GSCL) for fair resource distribution
A coordinated financial mechanism for emergency response from day one of a pandemic
Access to shared technologies and production knowledge, especially in developing countries
What is the WHO Pathogen Access and Benefit-Sharing System (PABS)?
The Pathogen Access and Benefit-Sharing System (PABS), still under negotiation, will govern how countries share biological materials and genome sequences and ensure fair return benefits like vaccines and diagnostics. The PABS annex will be finalised for consideration at the 2026 World Health Assembly.
The treaty also adopts a 'One Health' approach, acknowledging the link between human, animal and environmental health.
What happens next?
The agreement is now open for signature and ratification. It will become binding once ratified by 60 countries. Member states are expected to:
Begin aligning national laws with the agreement
Engage in the development of the PABS annex
Support WHO-led efforts to strengthen health systems, particularly in developing nations
Consider early ratification to expedite the treaty's entry into force
How will the agreement promote equity in vaccine distribution?
The agreement directly addresses vaccine inequity, a major issue during the Covid-19 pandemic. Pharmaceutical manufacturers will be required to reserve:
10 per cent of production for WHO-led donations
10 per cent at reduced prices for distribution to low-income nations
The agreement also discourages vaccine hoarding and promotes timely and transparent supply allocation to vulnerable populations.
What did WHO say about the significance of the treaty?
'The world is safer today thanks to the leadership, collaboration and commitment of our Member States to adopt the historic WHO Pandemic Agreement,' said WHO Director-General Dr Tedros Adhanom Ghebreyesus in a statement.
He added: 'The Agreement is a victory for public health, science and multilateral action. It will ensure we, collectively, can better protect the world from future pandemic threats. It is also a recognition by the international community that our citizens, societies and economies must not be left vulnerable to again suffer losses like those endured during Covid-19.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

COVID-19 May Trigger Alzheimer's-Like Protein Buildup In Brain And Eyes, Study Finds
COVID-19 May Trigger Alzheimer's-Like Protein Buildup In Brain And Eyes, Study Finds

NDTV

time40 minutes ago

  • NDTV

COVID-19 May Trigger Alzheimer's-Like Protein Buildup In Brain And Eyes, Study Finds

New research suggests that COVID-19 can lead to protein build-up similar to that seen in Alzheimer's patients, not just in the brain but also in the eyes. Elevated amyloid beta levels were found in the retinal tissue of people who had COVID-19, similar to Alzheimer's-like retinal conditions. Notably, Amyloid beta buildup is associated with Alzheimer's disease. Researchers analysed two proteins, neuropilin-1 (NRP1) and angiotensin-converting enzyme 2 (ACE2). The NRP1 protein may serve as an entry point for viruses into human eyes and brains. Researchers found that introducing an NRP1 inhibitor countered the amyloid beta increase caused by COVID-19's spike protein. The study, led by Yale University and published in Science Advances, sheds light on COVID-19 brain fog, which was a commonly reported symptom following infection. The researchers believe that amyloid beta may act as a bodyguard for the brain, indicating underlying danger. "There is growing evidence linking COVID-19 and brain fog, a commonly reported symptom following infection," senior author Brian Hafler, ophthalmologist at Yale School of Medicine, said as quoted by Science Alert. "While the mechanisms of brain fog after COVID-19 are not fully understood, scientists have found that SARS-CoV-2 can induce amyloid beta accumulation in the central nervous system." The research team is conducting clinical studies to determine if COVID-19 increases the long-term risk of developing Alzheimer's disease, to explore NRP1 inhibitors as potential therapeutics. The involvement of NRP1 in amyloid beta aggregation provides a specific molecular target for future investigation. Other viruses may trigger similar amyloid beta buildups, as there's a need for further research. This study contributes to understanding the complex relationship between COVID-19 and neurological health. "Our study showed that exposure to SARS-CoV-2, in particular spike protein, can lead to the formation of amyloid beta aggregates in both human retinal tissue and retinal organoids," Hafler says.

Healthcare at Heart of Viksit Bharat: Anupriya
Healthcare at Heart of Viksit Bharat: Anupriya

United News of India

timean hour ago

  • United News of India

Healthcare at Heart of Viksit Bharat: Anupriya

New Delhi, July 24 (UNI) Underscoring the crucial role of healthcare in building a developed India, Health Minister of State for Health & Family Welfare Anupriya Patel today said, 'Healthy India and Health for All are not just slogans, but the commitment of the government and a shared national vision.' She was addressing the Annual Convocation Ceremony of Lady Hardinge Medical College (LHMC) as the Chief Guest here. The event was also graced by Dr. VK Paul, member, NITI Aayog, and Dr. Sunita Sharma, Director General of Health Services, along with faculty, dignitaries and graduating students. In her keynote address, Patel stressed that India's aspiration to become a developed nation by 2047, as envisioned by Prime Minister Narendra Modi, depends heavily on a robust and equitable healthcare system. 'Healthcare is one of the foundational pillars of Viksit Bharat. Only a healthy nation can truly be a developed nation,' she said. Tracing the trajectory of India's health reforms, the Minister recalled the introduction of the National Health Policy in 2017, which laid the groundwork for a comprehensive, multi-dimensional health system — curative, preventive, promotive, palliative, and rehabilitative. She highlighted significant achievements including the establishment of Ayushman Arogya Mandirs, expansion of AIIMS from 7 to 23, and the adoption of digital health solutions. She further noted that India is advancing toward the WHO-recommended doctor-population ratio, and addressing the shortage of specialists in underserved regions. Government health spending, she said, has risen to nearly 2% of GDP, moving steadily toward the 2.5% target outlined in the national policy. The Minister cited flagship programmes such as Ayushman Bharat – PM-JAY, the world's largest health assurance scheme covering 55 crore citizens, and Jan Aushadhi Kendras, which ensure access to quality medicines at affordable prices. These interventions, she said, have led to a significant reduction in out-of-pocket expenditure on healthcare. Speaking on India's COVID-19 response, Patel stated, 'India's vaccination campaign was among the largest and fastest in the world, with over 220 crore doses administered.' She also urged LHMC graduates to continue the nation-building journey through medical research, digital innovation, and compassionate service. 'The medical profession is a rare blend of privilege and responsibility. Let your healing hands also carry the values of ethics, empathy and service to the underprivileged,' she told the students. The convocation also saw the launch of LHMC's Annual Report for 2024 and the Antibiotic Policy. UNI AJ ARN

On World IVF Day 2025, science and support reshape fertility journeys
On World IVF Day 2025, science and support reshape fertility journeys

Business Standard

time2 hours ago

  • Business Standard

On World IVF Day 2025, science and support reshape fertility journeys

With fertility rates on the decline and infertility affecting millions globally, awareness around alternative reproductive solutions has never been more crucial. According to the World Health Organization (WHO), one in six people worldwide are affected by infertility. Lifetime prevalence was 17.8 per cent in high-income countries and 16.5 per cent in low- and middle-income countries. These numbers not only reflect changing societal trends and health patterns, but also underline the growing demand for reproductive support systems such as in-vitro fertilisation (IVF) and other fertility treatment options. Why is World IVF Day celebrated on 25 July? World IVF Day is observed every year on 25 July, marking the birth of Louise Brown in 1978 — the world's first 'test-tube baby'. Her birth was a monumental milestone in medical science, achieved through the combined efforts of Dr Robert Geoffrey Edwards, Dr Patrick Christopher Steptoe and nurse Jean Marian Purdy. Dr Edwards was awarded the 2010 Nobel Prize for his work in developing IVF. Why World IVF Day is also Embryologist Day World IVF Day is also celebrated as World Embryologist Day to recognise and honour the contributions that embryologists have made to the field of medicine and reproductive health. Embryologists are highly trained scientists who handle eggs, sperm, and embryos in the lab, ensuring they are carefully monitored and developed before implantation. Without embryologists, the complex and delicate procedures involved in IVF would not be possible. What is IVF and who is it for? In-vitro fertilisation (IVF) is a medical process in which an egg is fertilised by sperm outside the body, and then implanted into the uterus. It is often used when other fertility treatments have failed, or in cases of unexplained infertility, advanced maternal age, genetic concerns, or certain health conditions in either partner. According to a 2022 report by Ernst and Young, there were around 2–2.5 lakh IVF cycles performed yearly in India. The report says that the Indian fertility industry is expected to reach $1,453 million by 2027 with the potential to carry out 5–6 lakh IVF cycles annually. The aim of IVF Day: Science, support, and awareness This day aims to highlight the breakthroughs in assisted reproductive technology and aims to: Raise awareness of infertility and available treatments Recognise scientific achievements in reproductive medicine Appreciate the emotional and physical journey of patients undergoing fertility treatments Celebrate the professionals, especially embryologists Why IVF awareness matters more than ever in India According to the State of World Population Report 2025 released by the United Nations Population Fund (UNFPA), India's total fertility rate (TFR) has now dropped to 2.0, slipping below the replacement level of 2.1. As fertility challenges become more common due to lifestyle changes, delayed parenthood, and health factors, awareness campaigns about alternative options serve an important purpose. They not only educate people about options like IVF, but also normalise seeking help and embracing science when needed. For more health updates, follow #HealthWithBS

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store